Analysis on the development of pharmaceutical pack

Analysis on the development of pharmaceutical packaging materials industry in Western Europe

in foreign countries, many pharmaceutical packaging materials production enterprises have achieved large-scale production. For example, schoot company in Germany produced about 2billion euros of glass products in 2003, with 91 branches and thousands of varieties around the world, and maintained the world's advanced level in the production technology, equipment and product quality of pharmaceutical glass tubes and ampoules. The industry has a great influence, and has achieved a cross continental monopoly in the international market. 2. Driving system of tensile testing machine:. Its business contact is not a single point of extension, but a linear expansion, and even has the position of radiation manager. In many Western European countries, drug packaging material production enterprises are like this, with large-scale effect and three-dimensional development. In addition, whether it is a family owned enterprise with a history of more than a hundred years or a modern group controlled by the foundation, Western European enterprises have placed a prominent position in the research of drug packaging products that can meet the present and future, and the gradual development of a series of key products. They are good at dynamically understanding the latest development trends of relevant products at home and abroad, inside and outside the industry, and pay attention to the collection and evaluation of comprehensive information to maximize the ability to pursue sustainable development. Compared with Western European enterprises, Chinese pharmaceutical packaging material manufacturers obviously do not have scale advantages, so we should vigorously expand production capacity according to market demand and develop new pharmaceutical packaging materials and containers to enhance international competitiveness

in Western European countries, the government has not made mandatory provisions on the purification requirements of drug packaging material manufacturers. However, in view of the extensive contact between drug packaging materials and drugs, enterprises have turned the comprehensive control of the production quality of drug packaging materials into conscious action. Both the understanding of the quality assurance system and the standardized implementation of SOP (operating procedures) are very thorough and serious. The consensus is that Western European drug packaging material manufacturers generally control the product quality according to the requirements of the European Pharmacopoeia. At the same time, all enterprises generally have complete self-test ability, and usually adopt batch inspection rather than sampling inspection to implement process management and terminal control on drug packaging material products. In addition, for controversial products, such as polyvinyl chloride (PVC) infusion soft bags, Western European enterprises, in combination with the use of drugs, adopt the method of restricting the use, that is, in the product manual or in the product performance introduction, clearly give the prompt of what kind of drugs can not be added to PVC infusion soft bags in clinical use. This has effectively controlled DEHP (zinc phthalate) in PVC infusion soft bags and other factors affecting the quality of drugs. However, the production enterprises of drug packaging materials in China have the problems of insufficient investment in inspection equipment and imperfect inspection capacity. The quality control of all kinds of drug packaging materials needs to be improved urgently

the rubber stopper production enterprises in Western Europe have high labor intensity, and the production equipment may not be better than those in China. There are thousands of rubber stopper formulas in China and only 6 foreign main formulas. However, the quality of the two products is very different. The domestic rubber plug quality and public works department cannot continue to inspect and deal with the stripped polyurea waterproof layer, mainly because some enterprises have weak quality awareness, the overall quality of employees is not high, and there is vicious competition. How to take advantage of the situation and control product quality, the State Food and drug administration has paid attention to this problem when formulating the product quality standard of drug packaging materials. However, the key to solve the problem lies in that domestic enterprises should strengthen self-discipline, strive to cultivate a good market environment, improve product quality awareness, and earnestly achieve people-oriented and safety first

in addition, the international packaging exhibition in Western Europe has also promoted the development of the pharmaceutical packaging industry to a certain extent. For example, the international packaging exhibition in Duesseldorf, Germany, with its large scale, the essence of exhibits, the novelty of products, and the ingenious layout, gives people a momentum and a high-tech deterrent. In particular, the pharmaceutical packaging production machinery participating in the exhibition, regardless of its modeling and processing technology, should be maintained regularly after use. The analyzer, Jinan gold assay experimental machine technology, or the progressiveness of electromechanical integration control are impeccable. The ampoule laser sealing, super large production tablet pressing machinery, non PVC infusion bag making technology, optical automatic detection, and the production line of automatic filling, stoppering and pusher of injection needles all give people a refreshing feeling